Eckhardt G, Goenechea S, Gielsdorf W
J Clin Chem Clin Biochem. 1977 Mar;15(3):115-20.
Mephenoxalone (5-(o-methoxyphenoxymethyl)-2-oxazolidone) is degraded by various routes in the human, and some is excreted unchanged. In the metabolism of mephenoxalone, the phenoxymethyl ether bond is cleaved; thus o-methoxyphenol (metabolite I) was identified in urine, and 3-amino-1,2-propanediol (IIa) was found after alkaline hydrolysis. Hydroxylation of the benzene ring produces a phenolic hydroxymephenoxalone (metabolite III), and demethylation converts mephenoxalone into demethylmepheonxalone (metabolite IV). Opening of the oxazolidone ring leads to the production of 1-(o-methoxyphenoxy)-3-aminopropane-2-ol(metabolite V). Urine contains two further substances: 1-(o-hydroxyphenoxy)-3-aminopropene (metabolite VI) and dehydromephenoxalone (metabolite VII). Metabolite VI may be an artefact. Compounds III, IV and VII could only be detected after acid hydrolysis and enzymic cleavage with beta-glucuronidase/aryl sulphatase, whereas V and VI were detected only after acid hydrolysis. Thin layer chromatography revealed three further metabolites, which were not identified.
美芬恶酮(5 - (邻甲氧基苯氧基甲基)-2 - 恶唑烷酮)在人体内通过多种途径降解,部分以原形排出。在美芬恶酮的代谢过程中,苯氧基甲基醚键断裂;因此,在尿液中鉴定出邻甲氧基苯酚(代谢物I),碱性水解后发现3 - 氨基 - 1,2 - 丙二醇(IIa)。苯环羟基化产生酚性羟基美芬恶酮(代谢物III),去甲基化将美芬恶酮转化为去甲基美芬恶酮(代谢物IV)。恶唑烷酮环开环导致生成1 - (邻甲氧基苯氧基)-3 - 氨基丙烷 - 2 - 醇(代谢物V)。尿液中还含有另外两种物质:1 - (邻羟基苯氧基)-3 - 氨基丙烯(代谢物VI)和脱氢美芬恶酮(代谢物VII)。代谢物VI可能是一种人工产物。化合物III、IV和VII仅在酸水解并用β - 葡萄糖醛酸酶/芳基硫酸酯酶进行酶解后才能检测到,而V和VI仅在酸水解后检测到。薄层色谱法显示还有另外三种未鉴定的代谢物。